Repligen Corp. buy UBS Group AG
Start price
16.01.26
/
50%
€138.90
Target price
16.01.27
-
Performance (%)
-19.44%
Price
15.04.26
€111.90
Summary
This prediction is currently active. The price of Repligen Corp. has decreased since the start of the prediction. Compared to the start price this results in a performance of -19.44%. This prediction currently runs until 16.01.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Repligen Corp. | 12.508% | 12.508% |
| iShares Core DAX® | 3.593% | 6.427% |
| iShares Nasdaq 100 | 5.810% | 6.381% |
| iShares Nikkei 225® | 4.075% | 9.307% |
| iShares S&P 500 | 4.142% | 4.938% |
Comments by UBS_Group_AG for this prediction
In the thread Repligen Corp. diskutieren
Repligen (NASDAQ:RGEN) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Ratings data for RGEN provided by MarketBeat
Stopped prediction by UBS_Group_AG for Repligen Corp.
Repligen Corp.
Start price
Target price
Perf. (%)
€154.80
31.07.24
31.07.24
€171.14
31.07.25
31.07.25
-34.59%
01.08.25
01.08.25
Repligen Corp.
Start price
Target price
Perf. (%)
€140.20
03.11.23
03.11.23
€158.58
03.11.24
03.11.24
-10.02%
04.11.24
04.11.24